Role of trace amine‑associated receptor 1 in the medial prefrontal cortex in chronic social stress-induced cognitive deficits in mice

TAAR1 agonists attenuate extended‐access cocaine self‐administration and yohimbine‐induced reinstatement of cocaine‐seeking

(2020) Jianfeng Liu et al.   BRITISH JOURNAL OF PHARMACOLOGY

A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia

(2020) Kenneth S. Koblan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prefrontal–hippocampal functional connectivity encodes recognition memory and is impaired in intellectual disability

(2020) Maria Alemany-González et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Trace Amine-Associated Receptor 1 Agonist Modulates Mismatch Negativity-Like Responses in Mice

(2019) Aleksander A. Aleksandrov et al.   Frontiers in Pharmacology

SEP-363856, A NOVEL PSYCHOTROPIC AGENT WITH A UNIQUE, NON-D2 RECEPTOR MECHANISM OF ACTION

(2019) Nina Dedic et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases

(2018) Michael D. Schwartz et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Trace Amines and Their Receptors

(2018) Raul R. Gainetdinov et al.   PHARMACOLOGICAL REVIEWS

The Case for TAAR1 as a Modulator of Central Nervous System Function

(2018) Grazia Rutigliano et al.   Frontiers in Pharmacology

Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397

(2018) Stefano Espinoza et al.   Frontiers in Pharmacology

Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers

(2018) Lisa M. Fleischer et al.   Frontiers in Pharmacology

Cognitive impairment in major depressive disorder

(2018) Zihang Pan et al.   CNS SPECTRUMS

Depression

(2018) Gin S Malhi et al.   LANCET

Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges

(2017) Mark D. Berry et al.   PHARMACOLOGY & THERAPEUTICS

Suppressed Calbindin Levels in Hippocampal Excitatory Neurons Mediate Stress-Induced Memory Loss

(2017) Ji-Tao Li et al.   Cell Reports

Cognitive remission: a novel objective for the treatment of major depression?

(2016) Beatrice Bortolato et al.   BMC Medicine

Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field

(2016) K.W. Miskowiak et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cellular and molecular basis for stress-induced depression

(2016) J-S Seo et al.   MOLECULAR PSYCHIATRY

Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications

(2016) Yue Pei et al.   Frontiers in Neuroscience

Neural circuitry for rat recognition memory

(2015) E.C. Warburton et al.   BEHAVIOURAL BRAIN RESEARCH

TAAR1 Modulates Cortical Glutamate NMDA Receptor Function

(2015) Stefano Espinoza et al.   NEUROPSYCHOPHARMACOLOGY

Spine synapse remodeling in the pathophysiology and treatment of depression

(2015) Catharine H. Duman et al.   NEUROSCIENCE LETTERS

Blockade of corticotropin-releasing hormone receptor 1 attenuates early-life stress-induced synaptic abnormalities in the neonatal hippocampus

(2014) Xue-Mei Liao et al.   HIPPOCAMPUS

Prefrontal Cortical Circuit for Depression- and Anxiety-Related Behaviors Mediated by Cholecystokinin: Role of  FosB

(2014) V. Vialou et al.   JOURNAL OF NEUROSCIENCE

Methamphetamine and HIV-1-induced neurotoxicity: Role of trace amine associated receptor 1 cAMP signaling in astrocytes

(2014) Irma E. Cisneros et al.   NEUROPHARMACOLOGY

Stress during a Critical Postnatal Period Induces Region-Specific Structural Abnormalities and Dysfunction of the Prefrontal Cortex via CRF1

(2014) Xiao-Dun Yang et al.   NEUROPSYCHOPHARMACOLOGY

COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONS

(2013) Roger S. McIntyre et al.   DEPRESSION AND ANXIETY

Homer1 Mediates Acute Stress-Induced Cognitive Deficits in the Dorsal Hippocampus

(2013) K. V. Wagner et al.   JOURNAL OF NEUROSCIENCE

The Brain on Stress: Vulnerability and Plasticity of the Prefrontal Cortex over the Life Course

(2013) Bruce S. McEwen et al.   NEURON

Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric Therapeutics

(2012) Florent G. Revel et al.   BIOLOGICAL PSYCHIATRY

Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold

(2012) Maria Elena Manni et al.   BRITISH JOURNAL OF PHARMACOLOGY

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

(2012) F G Revel et al.   MOLECULAR PSYCHIATRY

Repeated Stress Causes Cognitive Impairment by Suppressing Glutamate Receptor Expression and Function in Prefrontal Cortex

(2012) Eunice Y. Yuen et al.   NEURON

A standardized protocol for repeated social defeat stress in mice

(2011) Sam A Golden et al.   Nature Protocols

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

(2011) F. G. Revel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pituitary glucocorticoid receptor deletion reduces vulnerability to chronic stress

(2010) Klaus V. Wagner et al.   PSYCHONEUROENDOCRINOLOGY

Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression

(2009) Britta Haenisch et al.   JOURNAL OF NEUROCHEMISTRY

Chronic stress effects on dendritic morphology in medial prefrontal cortex: sex differences and estrogen dependence

(2009) J.E. Garrett et al.   NEUROSCIENCE

Animal models of anxiety: do I need multiple tests?

(2008) André Ramos   TRENDS IN PHARMACOLOGICAL SCIENCES